{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:52:42Z","timestamp":1782604362016,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12328-020-01274-6","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T08:06:46Z","timestamp":1604304406000},"page":"293-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Portal vein thrombosis due to essential thrombocythemia with limited cutaneous systemic sclerosis"],"prefix":"10.1007","volume":"14","author":[{"given":"Kentaro","family":"Iwaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3196-3494","authenticated-orcid":false,"given":"Yoshihide","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syoko","family":"Narukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Shiokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Seno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"key":"1274_CR1","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","volume":"12","author":"M \u00d6gren","year":"2006","unstructured":"\u00d6gren M, Bergqvist D, Bj\u00f6rck M, et al. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23796 consecutive autopsies. World J Gastroenterol. 2006;12:2115\u20139.","journal-title":"World J Gastroenterol"},{"key":"1274_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","volume":"128","author":"MA Elliott","year":"2005","unstructured":"Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol. 2005;128:275\u201390.","journal-title":"Br J Haematol"},{"key":"1274_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1182\/blood-2016-10-695957","volume":"129","author":"E Rumi","year":"2017","unstructured":"Rumi E, Cazzola M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood. 2017;129:680\u201392.","journal-title":"Blood"},{"issue":"8","key":"1274_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41408-018-0100-9","volume":"26","author":"G Finazzi","year":"2018","unstructured":"Finazzi G, De Stefano V, Barbui T. Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018. Blood Cancer J. 2018;26(8):64.","journal-title":"Blood Cancer J"},{"key":"1274_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1600-0609.2006.00715.x","volume":"77","author":"N Gangat","year":"2006","unstructured":"Gangat N, Wolanskyj AP, Tefferi A. Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications. Eur J Haematol. 2006;77:327\u201333.","journal-title":"Eur J Haematol"},{"key":"1274_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7:387\u201397.","journal-title":"Cancer Cell"},{"key":"1274_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/gtmb.2010.0093","volume":"15","author":"MW Ayad","year":"2011","unstructured":"Ayad MW, Nafea D. Acquired mutation of the tyrosine kinase JAK2V617F in Egyptian patients with myeloid disorders. Genet Test Mol Biomark. 2011;15:17\u201321.","journal-title":"Genet Test Mol Biomark"},{"key":"1274_CR8","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1182\/blood-2008-12-196014","volume":"113","author":"F Dentali","year":"2009","unstructured":"Dentali F, Squizzato A, Brivio L, et al. JAK2V617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood. 2009;113:5617\u201323.","journal-title":"Blood"},{"key":"1274_CR9","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3324\/haematol.2012.082560","volume":"98","author":"M Hurtado-Nedelec","year":"2013","unstructured":"Hurtado-Nedelec M, Csillag MJG, Boussetta T, et al. Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation. Haematologica. 2013;98:1517\u201324.","journal-title":"Haematologica"},{"key":"1274_CR10","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1182\/blood.V57.4.781.781","volume":"57","author":"H Castro-Malaspina","year":"1981","unstructured":"Castro-Malaspina H, Rabellino EM, Yen A, et al. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood. 1981;57:781\u20137.","journal-title":"Blood"},{"key":"1274_CR11","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1101\/gad.1653708","volume":"22","author":"J Andrae","year":"2008","unstructured":"Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22:1276\u2013312.","journal-title":"Genes Dev"},{"key":"1274_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","volume":"15","author":"JC Bonner","year":"2004","unstructured":"Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004;15:255\u201373.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1274_CR13","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa052955","volume":"354","author":"SS Baroni","year":"2006","unstructured":"Baroni SS, Santillo M, Bevilacqua F, et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med. 2006;354:2667\u201376.","journal-title":"N Engl J Med"},{"key":"1274_CR14","first-page":"75","volume":"8","author":"S Svegliati","year":"2017","unstructured":"Svegliati S, Amico D, Spadoni T, et al. Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro. Front Immunol. 2017;8:75.","journal-title":"Front Immunol"},{"key":"1274_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0190-9622(91)70010-Y","volume":"24","author":"PH Itin","year":"1991","unstructured":"Itin PH, Winkelmann RK. Cutaneous manifestations in patients with essential thrombocythemia. J Am Acad Dermatol. 1991;24:59\u201363.","journal-title":"J Am Acad Dermatol"},{"key":"1274_CR16","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1097\/DAD.0b013e31826b7325","volume":"35","author":"U Pielasinski","year":"2013","unstructured":"Pielasinski U, Haro R, Santonja C, et al. Essential thrombocythemia presenting as localized livedo reticularis. Am J Dermatopathol. 2013;35:e22\u20135.","journal-title":"Am J Dermatopathol"},{"key":"1274_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.clml.2015.08.086","volume":"15","author":"E Cozzani","year":"2015","unstructured":"Cozzani E, Iurlo A, Merlo G, et al. Essential thrombocythemia: the dermatologic point of view. Clin Lymphoma Myeloma Leuk. 2015;15:739\u201347.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1274_CR18","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jhsa.2007.05.010","volume":"32","author":"A Papadonikolakis","year":"2007","unstructured":"Papadonikolakis A, Chloros GD, Smith BP, et al. Digital ischemia due to essential thrombocythemia: a case report. J Hand Surg Am. 2007;32:1053\u20137.","journal-title":"J Hand Surg Am"},{"key":"1274_CR19","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","volume":"16","author":"HZ Ying","year":"2017","unstructured":"Ying HZ, Chen Q, Zhang WY, et al. PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (review). Mol Med Rep. 2017;16:7879\u201389.","journal-title":"Mol Med Rep"},{"key":"1274_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/BF02934089","volume":"32","author":"Y Ikura","year":"1997","unstructured":"Ikura Y, Morimoto H, Ogami M, et al. Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease. J Gastroenterol. 1997;32:496\u2013501.","journal-title":"J Gastroenterol"},{"key":"1274_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/alcalc\/agz094","volume":"55","author":"C Mart\u00edn-Gonz\u00e1lez","year":"2020","unstructured":"Mart\u00edn-Gonz\u00e1lez C, Gonz\u00e1lez-Navarrete L, Ribot-Hern\u00e1ndez I, et al. Platelet-derived growth factor c in alcoholics. Alcohol Alcohol. 2020;55:157\u201363.","journal-title":"Alcohol Alcohol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01274-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-020-01274-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01274-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:31:02Z","timestamp":1613694662000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-020-01274-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1274"],"URL":"https:\/\/doi.org\/10.1007\/s12328-020-01274-6","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,2]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Kentaro Iwaki, Yoshihide Ueda, Masako Mishima, Syoko Narukami, Masahiro Shiokawa, Kenji Sawada, Junya Kanda, Ken Takahashi and Hiroshi Seno declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}